CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief.

The analgesic activity of morphine-6-glucuronide. Br J Clin Pharmacol (1992) 1.23

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet (1999) 7.65

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet (1999) 7.56

Health effects of cadmium exposure--a review of the literature and a risk estimate. Scand J Work Environ Health (1998) 4.65

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet (2000) 4.09

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press (1992) 2.49

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project. Diabetes Care (2001) 2.39

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain (1992) 1.89

Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension. Eur J Clin Pharmacol (1983) 1.77

Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol (1991) 1.66

Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64

[There is no reason to avoid calcium antagonists in hypertension]. Lakartidningen (1996) 1.62

Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl (1988) 1.55

Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54

Factors associated with survival to hospital discharge among patients hospitalised alive after out of hospital cardiac arrest: change in outcome over 20 years in the community of Göteborg, Sweden. Heart (2003) 1.53

Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. Lancet (2001) 1.52

Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ (1994) 1.52

Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris. Cardiology (1998) 1.51

Analysis of initial rhythm, witnessed status and delay to treatment among survivors of out-of-hospital cardiac arrest in Sweden. Heart (2010) 1.47

Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic beta2 receptor in a Swedish hypertensive population. J Hum Hypertens (2005) 1.45

Psychotropic drug use in pregnancy and perinatal death. Acta Obstet Gynecol Scand (1992) 1.39

Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. Am J Hypertens (1991) 1.39

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetes Care (2008) 1.37

Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. Br J Clin Pharmacol (1983) 1.35

The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28

Topical anesthesia with lidocaine aerosol in the control of postoperative pain. Anesthesiology (1988) 1.27

Brain natriuretic peptide predicts mortality in the elderly. Heart (1997) 1.27

Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. Acta Physiol Scand (1988) 1.27

There is a difference in characteristics and outcome between women and men who suffer out of hospital cardiac arrest. Resuscitation (1999) 1.26

The cost-effectiveness of a cardiovascular multiple-risk-factor intervention programme in treated hypertensive men. J Intern Med (1995) 1.25

Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res (1995) 1.22

Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21

Adenosine mechanisms in the regulation of breathing in the rat. Eur J Pharmacol (1984) 1.20

Water intoxication associated with non-steroidal anti-inflammatory drug therapy. Acta Med Scand (1987) 1.18

Carcinomas of the respiratory tract in hamsters given arsenic trioxide and/or benzo[a]pyrene by the pulmonary route. Environ Res (1984) 1.18

Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol (1991) 1.16

STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension. Blood Press (1993) 1.15

Atrial natriuretic peptides predict mortality in the elderly. J Intern Med (1997) 1.14

Short-term effects of felodipine, a new dihydropyridine, in hypertension. Br J Clin Pharmacol (1984) 1.14

Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. J Pharm Pharmacol (1982) 1.14

Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens (1990) 1.13

Clara cell protein as a biomarker for ozone-induced lung injury in humans. Eur Respir J (2003) 1.13

Pain and pulmonary function following laparoscopic and abdominal hysterectomy: a randomized study. Acta Obstet Gynecol Scand (1998) 1.12

Microprobe analysis of lead in human femur by proton induced X-ray emission (PIXE). Sci Total Environ (1978) 1.12

Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry. Psychiatry Res (1999) 1.11

Mortality and lead exposure: a retrospective cohort study of Swedish smelter workers. Br J Ind Med (1986) 1.10

Treatment of essential hypertension with felodipine in combination with a diuretic. Eur J Clin Pharmacol (1986) 1.10

Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain (1994) 1.09

Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension. Drugs (1985) 1.08

Antihypertensive effects of felodipine compared with placebo. Drugs (1985) 1.07

Sweep-tone measurements of vocal-tract characteristics. J Acoust Soc Am (1971) 1.06

Urinary calcium as a biomarker of renal dysfunction in a general population exposed to cadmium. J Occup Environ Med (2001) 1.05

Evaluation of dispatcher-assisted cardiopulmonary resuscitation. Eur J Emerg Med (1999) 1.03

Perceived symptoms amongst hypertensive patients in routine clinical practice- a population-based study. J Intern Med (1998) 1.03

Ambulatory blood pressure 16-26 years after the first urinary tract infection in childhood. J Hypertens (2000) 1.02

Long-term prognosis among survivors after in-hospital cardiac arrest. Resuscitation (2000) 1.02

Improvement in the hospital organisation of CPR training and outcome after cardiac arrest in Sweden during a 10-year period. Resuscitation (2011) 1.02

Levels of antimony, arsenic, cadmium, copper, lead, mercury, selenium, silver, tin and zinc in bone tissue of industrially exposed workers. Sci Total Environ (1980) 1.02

Ketanserin in essential hypertension: effects during rest and exercise. Eur J Clin Pharmacol (1983) 1.02

Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. J Neural Transm (1985) 1.01

Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand (1998) 1.00

Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction. Heart Lung (1997) 0.99

Urinary N-acetyl-beta-D-glucosaminidase isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population. Environ Res (1999) 0.99

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension (1998) 0.99

Atrial peptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population. Eur Heart J (1993) 0.99

Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res (1999) 0.98

Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension. Br J Clin Pharmacol (1984) 0.97

Regulation of breathing in the rat: indications for a role of central adenosine mechanisms. Neurosci Lett (1982) 0.97

Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. Maturitas (1994) 0.97

Intraarticular morphine after arthroscopic ACL reconstruction: a double-blind placebo-controlled study of 40 patients. Acta Orthop Scand (2000) 0.96

Can we define patients with no and those with some chance of survival when found in asystole out of hospital? Am J Cardiol (2000) 0.96

Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. Life Sci (1999) 0.96

Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain. Br J Clin Pharmacol (2005) 0.95

Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol (1994) 0.95

Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.94

Characteristics and outcome among patients with a suspected in-hospital cardiac arrest. Resuscitation (1999) 0.94

Pressure-volume relationship and fluid content in fetal rabbit lung after beta-receptor-stimulating drugs. Pediatr Res (1980) 0.94

Renal and hemodynamic effects of isradipine in essential hypertension. Am J Med (1989) 0.94

The neuropharmacology of respiratory control. Pharmacol Rev (1982) 0.93

Cadmium-induced apoptosis and changes in expression of p53, c-jun and MT-I genes in testes and ventral prostate of rats. Toxicology (1999) 0.93

Is hospital care of major importance for outcome after out-of-hospital cardiac arrest? Experience acquired from patients with out-of-hospital cardiac arrest resuscitated by the same Emergency Medical Service and admitted to one of two hospitals over a 16-year period in the municipality of Göteborg. Resuscitation (2000) 0.93

Cadmium exposure among residents in an area contaminated by irrigation water in China. Bull World Health Organ (1995) 0.93

A comparative and long-term evaluation of ketanserin in the treatment of essential hypertension. J Cardiovasc Pharmacol (1985) 0.93

Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology (1984) 0.92

Enhanced pressor responses to experimental and daily-life stress in borderline hypertension. J Hypertens (1995) 0.92

Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden. J Hum Hypertens (1994) 0.92

Central, naloxone-reversible antinociception by diclofenac in the rat. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.92

Felodipine. A calcium-inhibiting vasodilator in refractory hypertension. Drugs (1985) 0.91

COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs. Clin Rheumatol (2000) 0.91

Accelerated uptake of mercury by brain caused by 2,3-dimercaptopropanol (BAL) after injection into the mouse of a methylmercuric compound. Acta Pharmacol Toxicol (Copenh) (1965) 0.91

Pharmacokinetics of ketanserin in patients with essential hypertension. Eur J Clin Pharmacol (1987) 0.91

Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med (1996) 0.91

Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension (1998) 0.91

Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A. Nephrol Dial Transplant (1993) 0.91

Brain natriuretic peptide in an elderly population. J Intern Med (1997) 0.91

Antepartum administration of terbutaline and the incidence of hyaline membrane disease in preterm infants. Acta Obstet Gynecol Scand (1978) 0.91

Survivors of out of hospital cardiac arrest: their prognosis, longevity and functional status. Resuscitation (1997) 0.91

Increased plasma levels of atrial natriuretic peptide (ANP) in patients with paroxysmal supraventricular tachyarrhythmias. Acta Med Scand (1987) 0.91

The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Endocrinology (2000) 0.90